カテゴリー： GlobalInfoResearch, 世界

結膜炎治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Conjunctivitis Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101958）・商品コード：GIR9101958
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、結膜炎治療薬の世界市場について調べ、まとめました。種類別セグメントは、アレルギー性結膜炎、細菌性結膜炎、ウイルス性結膜炎等、用途別セグメントは、病院、外来等に区分しました。結膜炎治療薬の世界市場概観、メーカー動向、メーカー別結膜炎治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・結膜炎治療薬の市場概観
・結膜炎治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・結膜炎治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・結膜炎治療薬の世界市場規模
・結膜炎治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・結膜炎治療薬のアメリカ市場規模推移
・結膜炎治療薬のカナダ市場規模推移
・結膜炎治療薬のメキシコ市場規模推移
・結膜炎治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・結膜炎治療薬のドイツ市場規模推移
・結膜炎治療薬のイギリス市場規模推移
・結膜炎治療薬のロシア市場規模推移
・結膜炎治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・結膜炎治療薬の日本市場規模推移
・結膜炎治療薬の中国市場規模推移
・結膜炎治療薬の韓国市場規模推移
・結膜炎治療薬のインド市場規模推移
・結膜炎治療薬の東南アジア市場規模推移
・結膜炎治療薬の南米市場分析（ブラジル、アルゼンチン等）
・結膜炎治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・結膜炎治療薬の種類別分析/販売量、売上、市場シェア（アレルギー性結膜炎、細菌性結膜炎、ウイルス性結膜炎）
・結膜炎治療薬の用途別分析/市場規模（病院、外来）
・結膜炎治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・結膜炎治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Conjunctivitis is an inflammation or swelling of the conjunctiva.

Scope of the Report:
The worldwide market for Conjunctivitis Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Conjunctivitis Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Akorn, Incorporated
ALLERGAN
Bausch Health
Novartis AG
Santen Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Allergic conjunctivitis
Bacterial conjunctivitis
Viral conjunctivitis

Market Segment by Applications, can be divided into
Hospital
Outpatient

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Conjunctivitis Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Conjunctivitis Therapeutics, with price, sales, revenue and global market share of Conjunctivitis Therapeutics in 2017 and 2018.
Chapter 3, the Conjunctivitis Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjunctivitis Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Conjunctivitis Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Conjunctivitis Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Conjunctivitis Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Allergic conjunctivitis
1.2.2 Bacterial conjunctivitis
1.2.3 Viral conjunctivitis
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Outpatient
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Akorn, Incorporated
2.1.1 Business Overview
2.1.2 Conjunctivitis Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Akorn, Incorporated Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 ALLERGAN
2.2.1 Business Overview
2.2.2 Conjunctivitis Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ALLERGAN Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bausch Health
2.3.1 Business Overview
2.3.2 Conjunctivitis Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bausch Health Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Conjunctivitis Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Santen Pharmaceutical
2.5.1 Business Overview
2.5.2 Conjunctivitis Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Santen Pharmaceutical Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Conjunctivitis Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Conjunctivitis Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Conjunctivitis Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Conjunctivitis Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Conjunctivitis Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Conjunctivitis Therapeutics Market Analysis by Regions
4.1 Global Conjunctivitis Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Conjunctivitis Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Conjunctivitis Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
5 North America Conjunctivitis Therapeutics by Country
5.1 North America Conjunctivitis Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Conjunctivitis Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Conjunctivitis Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Conjunctivitis Therapeutics by Country
6.1 Europe Conjunctivitis Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Conjunctivitis Therapeutics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Conjunctivitis Therapeutics Revenue and Market Share by Country (2014-2019)
6.2 Germany Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
6.3 UK Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
6.4 France Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
6.5 Russia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
6.6 Italy Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Conjunctivitis Therapeutics by Country
7.1 Asia-Pacific Conjunctivitis Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Conjunctivitis Therapeutics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Conjunctivitis Therapeutics Revenue and Market Share by Country (2014-2019)
7.2 China Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
7.3 Japan Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
7.4 Korea Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
7.5 India Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
8 South America Conjunctivitis Therapeutics by Country
8.1 South America Conjunctivitis Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Conjunctivitis Therapeutics Sales and Market Share by Country (2014-2019)
8.1.2 South America Conjunctivitis Therapeutics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
8.3 Argentina Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
8.4 Colombia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Conjunctivitis Therapeutics by Countries
9.1 Middle East and Africa Conjunctivitis Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Conjunctivitis Therapeutics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Conjunctivitis Therapeutics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
9.3 Turkey Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
9.4 Egypt Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
9.5 Nigeria Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
9.6 South Africa Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
10 Global Conjunctivitis Therapeutics Market Segment by Type
10.1 Global Conjunctivitis Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Conjunctivitis Therapeutics Sales and Market Share by Type (2014-2019)
10.1.2 Global Conjunctivitis Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Allergic conjunctivitis Sales Growth and Price
10.2.1 Global Allergic conjunctivitis Sales Growth (2014-2019)
10.2.2 Global Allergic conjunctivitis Price (2014-2019)
10.3 Bacterial conjunctivitis Sales Growth and Price
10.3.1 Global Bacterial conjunctivitis Sales Growth (2014-2019)
10.3.2 Global Bacterial conjunctivitis Price (2014-2019)
10.4 Viral conjunctivitis Sales Growth and Price
10.4.1 Global Viral conjunctivitis Sales Growth (2014-2019)
10.4.2 Global Viral conjunctivitis Price (2014-2019)
11 Global Conjunctivitis Therapeutics Market Segment by Application
11.1 Global Conjunctivitis Therapeutics Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Outpatient Sales Growth (2014-2019)
12 Conjunctivitis Therapeutics Market Forecast (2019-2024)
12.1 Global Conjunctivitis Therapeutics Sales, Revenue and Growth Rate (2019-2024)
12.2 Conjunctivitis Therapeutics Market Forecast by Regions (2019-2024)
12.2.1 North America Conjunctivitis Therapeutics Market Forecast (2019-2024)
12.2.2 Europe Conjunctivitis Therapeutics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Conjunctivitis Therapeutics Market Forecast (2019-2024)
12.2.4 South America Conjunctivitis Therapeutics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Conjunctivitis Therapeutics Market Forecast (2019-2024)
12.3 Conjunctivitis Therapeutics Market Forecast by Type (2019-2024)
12.3.1 Global Conjunctivitis Therapeutics Sales Forecast by Type (2019-2024)
12.3.2 Global Conjunctivitis Therapeutics Market Share Forecast by Type (2019-2024)
12.4 Conjunctivitis Therapeutics Market Forecast by Application (2019-2024)
12.4.1 Global Conjunctivitis Therapeutics Sales Forecast by Application (2019-2024)
12.4.2 Global Conjunctivitis Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Conjunctivitis Therapeutics Picture
Table Product Specifications of Conjunctivitis Therapeutics
Figure Global Sales Market Share of Conjunctivitis Therapeutics by Types in 2018
Table Conjunctivitis Therapeutics Types for Major Manufacturers
Figure Allergic conjunctivitis Picture
Figure Bacterial conjunctivitis Picture
Figure Viral conjunctivitis Picture
Figure Conjunctivitis Therapeutics Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Outpatient Picture
Figure United States Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure France Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure UK Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure China Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure India Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Conjunctivitis Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Table Akorn, Incorporated Basic Information, Manufacturing Base and Competitors
Table Akorn, Incorporated Conjunctivitis Therapeutics Type and Applications
Table Akorn, Incorporated Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ALLERGAN Basic Information, Manufacturing Base and Competitors
Table ALLERGAN Conjunctivitis Therapeutics Type and Applications
Table ALLERGAN Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Conjunctivitis Therapeutics Type and Applications
Table Bausch Health Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Conjunctivitis Therapeutics Type and Applications
Table Novartis AG Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Santen Pharmaceutical Conjunctivitis Therapeutics Type and Applications
Table Santen Pharmaceutical Conjunctivitis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Conjunctivitis Therapeutics Sales by Manufacturer (2017-2018)
Figure Global Conjunctivitis Therapeutics Sales Market Share by Manufacturer in 2017
Figure Global Conjunctivitis Therapeutics Sales Market Share by Manufacturer in 2018
Table Global Conjunctivitis Therapeutics Revenue by Manufacturer (2017-2018)
Figure Global Conjunctivitis Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Global Conjunctivitis Therapeutics Revenue Market Share by Manufacturer in 2018
Figure Top 3 Conjunctivitis Therapeutics Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Conjunctivitis Therapeutics Manufacturer (Revenue) Market Share in 2018
Figure Global Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Global Conjunctivitis Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Conjunctivitis Therapeutics Sales by Regions (2014-2019)
Table Global Conjunctivitis Therapeutics Sales Market Share by Regions (2014-2019)
Table Global Conjunctivitis Therapeutics Revenue by Regions (2014-2019)
Figure Global Conjunctivitis Therapeutics Revenue Market Share by Regions in 2014
Figure Global Conjunctivitis Therapeutics Revenue Market Share by Regions in 2018
Figure North America Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Europe Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure South America Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure North America Conjunctivitis Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Conjunctivitis Therapeutics Sales by Countries (2014-2019)
Table North America Conjunctivitis Therapeutics Sales Market Share by Countries (2014-2019)
Figure North America Conjunctivitis Therapeutics Sales Market Share by Countries in 2014
Figure North America Conjunctivitis Therapeutics Sales Market Share by Countries in 2018
Table North America Conjunctivitis Therapeutics Revenue by Countries (2014-2019)
Table North America Conjunctivitis Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Conjunctivitis Therapeutics Revenue Market Share by Countries in 2014
Figure North America Conjunctivitis Therapeutics Revenue Market Share by Countries in 2018
Figure United States Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Canada Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Mexico Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Europe Conjunctivitis Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Conjunctivitis Therapeutics Sales by Countries (2014-2019)
Table Europe Conjunctivitis Therapeutics Sales Market Share by Countries (2014-2019)
Table Europe Conjunctivitis Therapeutics Revenue by Countries (2014-2019)
Figure Europe Conjunctivitis Therapeutics Revenue Market Share by Countries in 2017
Figure Europe Conjunctivitis Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure UK Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure France Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Russia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Italy Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Conjunctivitis Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Conjunctivitis Therapeutics Sales by Countries (2014-2019)
Table Asia-Pacific Conjunctivitis Therapeutics Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Conjunctivitis Therapeutics Sales Market Share by Countries 2018
Table Asia-Pacific Conjunctivitis Therapeutics Revenue by Countries (2014-2019)
Figure Asia-Pacific Conjunctivitis Therapeutics Revenue Market Share by Countries 2018
Figure China Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Japan Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Korea Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure India Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Southeast Asia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure South America Conjunctivitis Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Conjunctivitis Therapeutics Sales by Countries (2014-2019)
Table South America Conjunctivitis Therapeutics Sales Market Share by Countries (2014-2019)
Figure South America Conjunctivitis Therapeutics Sales Market Share by Countries in 2018
Table South America Conjunctivitis Therapeutics Revenue by Countries (2014-2019)
Table South America Conjunctivitis Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Conjunctivitis Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Argentina Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Colombia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Conjunctivitis Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Conjunctivitis Therapeutics Sales by Countries (2014-2019)
Table Middle East and Africa Conjunctivitis Therapeutics Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Conjunctivitis Therapeutics Sales Market Share by Countries in 2018
Table Middle East and Africa Conjunctivitis Therapeutics Revenue by Countries (2014-2019)
Table Middle East and Africa Conjunctivitis Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Conjunctivitis Therapeutics Revenue Market Share by Countries in 2014
Figure Middle East and Africa Conjunctivitis Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure UAE Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Egypt Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure Nigeria Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Figure South Africa Conjunctivitis Therapeutics Sales and Growth Rate (2014-2019)
Table Global Conjunctivitis Therapeutics Sales by Type (2014-2019)
Table Global Conjunctivitis Therapeutics Sales Share by Type (2014-2019)
Table Global Conjunctivitis Therapeutics Revenue by Type (2014-2019)
Table Global Conjunctivitis Therapeutics Revenue Share by Type (2014-2019)
Figure Global Allergic conjunctivitis Sales Growth (2014-2019)
Figure Global Allergic conjunctivitis Price (2014-2019)
Figure Global Bacterial conjunctivitis Sales Growth (2014-2019)
Figure Global Bacterial conjunctivitis Price (2014-2019)
Figure Global Viral conjunctivitis Sales Growth (2014-2019)
Figure Global Viral conjunctivitis Price (2014-2019)
Table Global Conjunctivitis Therapeutics Sales by Application (2014-2019)
Table Global Conjunctivitis Therapeutics Sales Share by Application (2014-2019)
Figure Global Outpatient Sales Growth (2014-2019)
Figure Global Conjunctivitis Therapeutics Sales, Revenue and Growth Rate (2019-2024)
Table Global Conjunctivitis Therapeutics Sales Forecast by Regions (2019-2024)
Table Global Conjunctivitis Therapeutics Market Share Forecast by Regions (2019-2024)
Figure North America Sales Conjunctivitis Therapeutics Market Forecast (2019-2024)
Figure Europe Sales Conjunctivitis Therapeutics Market Forecast (2019-2024)
Figure Asia-Pacific Sales Conjunctivitis Therapeutics Market Forecast (2019-2024)
Figure South America Sales Conjunctivitis Therapeutics Market Forecast (2019-2024)
Figure Middle East and Africa Sales Conjunctivitis Therapeutics Market Forecast (2019-2024)
Table Global Conjunctivitis Therapeutics Sales Forecast by Type (2019-2024)
Table Global Conjunctivitis Therapeutics Market Share Forecast by Type (2019-2024)
Table Global Conjunctivitis Therapeutics Sales Forecast by Application (2019-2024)
Table Global Conjunctivitis Therapeutics Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Akorn, Incorporated、ALLERGAN、Bausch Health、Novartis AG、Santen Pharmaceutical、

★調査レポート[結膜炎治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101958)販売に関する免責事項を必ずご確認ください。
★調査レポート[結膜炎治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 新生児結膜炎治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101960 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、新生児結膜炎治療薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所、筋肉内および静脈内等、用途別セグメントは、病院薬局、小売薬局、その他等に区分しました。新生児結膜炎治療薬の世界市場概観、メーカー動向、メーカー別新生児結膜炎治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・新生児結膜炎治療薬の市場概観 ・新生児結膜炎治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・新生児結膜炎治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・新生児結膜炎治療薬の世界市場規模 ・新生児結膜炎治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・新生児結膜炎治療薬のアメリカ市場規模推移 ・新生児結膜炎治療薬のカナダ市場規模推移 ・新生児結膜炎治療薬のメキシコ市場規模推移 ・新生児結膜炎治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Neonatal Conjunctivitis is also known as Opthalmia Neonatorum. Neonatal conjunctivitis manifests in the infant within the first 28 days of being born. Scope of the Report: The worldwide market for Neonatal Conjunctivitis Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Neonatal Conjunctivitis Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based...
  • アレルギー性結膜炎治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101959 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、アレルギー性結膜炎治療の世界市場について調べ、まとめました。種類別セグメントは、急性アレルギー性結膜炎、慢性アレルギー性結膜炎等、用途別セグメントは、病院、外来等に区分しました。アレルギー性結膜炎治療の世界市場概観、メーカー動向、メーカー別アレルギー性結膜炎治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アレルギー性結膜炎治療の市場概観 ・アレルギー性結膜炎治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アレルギー性結膜炎治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・アレルギー性結膜炎治療の世界市場規模 ・アレルギー性結膜炎治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・アレルギー性結膜炎治療のアメリカ市場規模推移 ・アレルギー性結膜炎治療のカナダ市場規模推移 ・アレルギー性結膜炎治療のメキシコ市場規模推移 ・アレルギー性結膜炎治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Swelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due to allergens in patients such as household dust, mold spores, pollen from trees and grass, chemical scents (e.g., household detergents or perfume) and animal dander. Scope of the Report: The worldwide market for Allergic Conjunctivitis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the...
  • 急性および慢性アレルギー性結膜炎の治療の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101962 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、急性および慢性アレルギー性結膜炎の治療の世界市場について調べ、まとめました。種類別セグメントは、急性アレルギー性結膜炎、慢性アレルギー性結膜炎等、用途別セグメントは、病院、外来等に区分しました。急性および慢性アレルギー性結膜炎の治療の世界市場概観、メーカー動向、メーカー別急性および慢性アレルギー性結膜炎の治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・急性および慢性アレルギー性結膜炎の治療の市場概観 ・急性および慢性アレルギー性結膜炎の治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・急性および慢性アレルギー性結膜炎の治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・急性および慢性アレルギー性結膜炎の治療の世界市場規模 ・急性および慢性アレルギー性結膜炎の治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・急性および慢性アレルギー性結膜炎の治療のアメリカ市場規模推移 ・急性および慢性アレルギー性結膜炎の治療のカナダ市場規模推移 ・急性および慢性アレルギー性結膜炎の治療のメキシコ市場規模推移 ・急性および慢性アレルギー性結膜炎の治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Swelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due to allergens in patients such as household dust, mold spores, pollen from trees and grass, chemical scents (e.g., household detergents or perfume) and animal dander. Scope of the Report: The worldwide market for Acute and Chronic Allergic Conjunctivitis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report...
  • 抗ヒスタミン点眼薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101577 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、抗ヒスタミン点眼薬の世界市場について調べ、まとめました。種類別セグメントは、急性アレルギー性結膜炎、慢性アレルギー性結膜炎等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。抗ヒスタミン点眼薬の世界市場概観、メーカー動向、メーカー別抗ヒスタミン点眼薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗ヒスタミン点眼薬の市場概観 ・抗ヒスタミン点眼薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗ヒスタミン点眼薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗ヒスタミン点眼薬の世界市場規模 ・抗ヒスタミン点眼薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗ヒスタミン点眼薬のアメリカ市場規模推移 ・抗ヒスタミン点眼薬のカナダ市場規模推移 ・抗ヒスタミン点眼薬のメキシコ市場規模推移 ・抗ヒスタミン点眼薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Ketotifen is an antihistamine for the eye that treats allergic symptoms by blocking a certain natural substance. Scope of the Report: The worldwide market for Antihistamine Eye Drops is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Antihistamine Eye Drops in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and...
  • 細菌性眼感染症治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101961 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、細菌性眼感染症治療薬の世界市場について調べ、まとめました。種類別セグメントは、軟膏、目薬、医薬品等、用途別セグメントは、病院薬局、小売薬局、その他等に区分しました。細菌性眼感染症治療薬の世界市場概観、メーカー動向、メーカー別細菌性眼感染症治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・細菌性眼感染症治療薬の市場概観 ・細菌性眼感染症治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・細菌性眼感染症治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・細菌性眼感染症治療薬の世界市場規模 ・細菌性眼感染症治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・細菌性眼感染症治療薬のアメリカ市場規模推移 ・細菌性眼感染症治療薬のカナダ市場規模推移 ・細菌性眼感染症治療薬のメキシコ市場規模推移 ・細菌性眼感染症治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...It is a serious eye infection caused by several types of bacteria.  Scope of the Report: The worldwide market for Bacterial Eye Infection Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Bacterial Eye Infection Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment...
  • アレルギー緩和目薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102154 / GlobalInfoResearch / 2019年9月17日 / 本調査レポートは、アレルギー緩和目薬の世界市場について調べ、まとめました。種類別セグメントは、季節性アレルギー性結膜炎、通年性アレルギー性結膜炎等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。アレルギー緩和目薬の世界市場概観、メーカー動向、メーカー別アレルギー緩和目薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アレルギー緩和目薬の市場概観 ・アレルギー緩和目薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アレルギー緩和目薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・アレルギー緩和目薬の世界市場規模 ・アレルギー緩和目薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・アレルギー緩和目薬のアメリカ市場規模推移 ・アレルギー緩和目薬のカナダ市場規模推移 ・アレルギー緩和目薬のメキシコ市場規模推移 ・アレルギー緩和目薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Allergy Relief Eye Drops are Eye Drops used for Allergy treatment Scope of the Report: The worldwide market for Allergy Relief Eye Drops is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Allergy Relief Eye Drops in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by...
  • 眼感染症薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101222 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、眼感染症薬の世界市場について調べ、まとめました。種類別セグメントは、レボフロキサシン、シプロフロキサシン、その他等、用途別セグメントは、結膜炎、麦粒腫、まぶたの感染、その他等に区分しました。眼感染症薬の世界市場概観、メーカー動向、メーカー別眼感染症薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・眼感染症薬の市場概観 ・眼感染症薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・眼感染症薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・眼感染症薬の世界市場規模 ・眼感染症薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・眼感染症薬のアメリカ市場規模推移 ・眼感染症薬のカナダ市場規模推移 ・眼感染症薬のメキシコ市場規模推移 ・眼感染症薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Eye Infection Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Eye Infection Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Novartis Allergan Valeant Pharmaceuticals Santen Pharmaceutical Lupin Pharmaceuticals...

    • ◆H&Iグローバルリサーチのお客様（例）◆